Get the Stockscreener App
60.94
3.94%
-2.50
After Hours:
60.45
-0.49
-0.80%
Kiniksa Pharmaceuticals International Plc stock is traded at $60.94, with a volume of 585.26K.
It is down -3.94% in the last 24 hours and up +17.44% over the past month.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
See More
Previous Close:
$63.44
Open:
$63.43
24h Volume:
585.26K
Relative Volume:
0.74
Market Cap:
$4.69B
Revenue:
$754.05M
Net Income/Loss:
$73.06M
P/E Ratio:
67.17
EPS:
0.9073
Net Cash Flow:
$164.23M
1W Performance:
-2.92%
1M Performance:
+17.44%
6M Performance:
+57.88%
1Y Performance:
+116.95%
1-Day Range:
$60.89
$63.64
1-Week Range:
$60.89
$67.53
52-Week Range:
$26.27
$67.53
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Company Profile
Name
Kiniksa Pharmaceuticals International Plc
Sector
Phone
(781) 431-9100
Address
105 PICCADILLY, SECOND FLOOR, LONDON
Compare KNSA vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KNSA
Kiniksa Pharmaceuticals International Plc
|
60.94 | 4.88B | 754.05M | 73.06M | 164.23M | 0.9073 |
TAK
Takeda Pharmaceutical Co Adr
|
16.48 | 52.88B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.865 | 42.98B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.16 | 38.37B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
75.39 | 31.68B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
535.57 | 23.22B | 3.17B | 1.29B | 1.01B | 27.09 |
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-19-26 | Initiated | Canaccord Genuity | Buy |
| Sep-29-25 | Initiated | TD Cowen | Buy |
| Mar-13-25 | Initiated | Citigroup | Buy |
| Sep-13-24 | Initiated | Jefferies | Buy |
| May-03-24 | Initiated | Wells Fargo | Overweight |
| Jun-29-20 | Reiterated | BofA Securities | Buy |
| Apr-01-20 | Initiated | BofA/Merrill | Buy |
| Mar-11-19 | Initiated | Barclays | Overweight |
| Dec-12-18 | Reiterated | Wedbush | Outperform |
| Jun-19-18 | Initiated | JMP Securities | Mkt Outperform |
View All
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Latest News
KNSA Maintained by Wells Fargo -- Price Target Raised to $74.00 - GuruFocus
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Kiniksa Pharmaceuticals International, plc (KNSA) surges 5.4%: Is this an indication of further gains? - MSN
Kiniksa Pharmaceuticals International (KNSA) Joins Russell Indexes, Is The Upside Already Priced In? - Yahoo Finance
Illumina, Inc. (ILMN) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Kiniksa Pharmaceuticals International PLC (KNSA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Kiniksa Pharmaceuticals International PLC (KNSA) Shares Surge 7. - GuruFocus
Will Broad Russell Index Inclusion Reshape Kiniksa Pharmaceuticals' (KNSA) ARCALYST-Centered Growth Narrative? - simplywall.st
Performance share awards at Kiniksa (NASDAQ: KNSA) tied to KPL-387 FDA goals - Stock Titan
Kiniksa (KNSA) Chief Strategy Officer named as insider in Form 3 - Stock Titan
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 12-Month HighHere's What Happened - MarketBeat
Kiniksa Pharmaceuticals International, plc (KNSA) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance
Here's why you should add Kiniksa stock to your portfolio now - MSN
What makes Kiniksa Pharmaceuticals International, plc (KNSA) a strong momentum stock: Buy now? - MSN
Kiniksa Pharmaceuticals Hits New 52-Week High of USD 59.89 - MarketsMojo
Kiniksa Pharmaceuticals Hits New 52-Week High of USD 63.77 - MarketsMojo
Peregrine Capital Management LLC Sells 29,550 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Inspire Investing LLC Makes New $1.70 Million Investment in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Pictet Asset Management Holding SA Sells 164,232 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
What Makes Kiniksa Pharmaceuticals International, plc (KNSA) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Kiniksa Pharmaceuticals International, plc (KNSA) Surges 5.4%: Is This an Indication of Further Gains? - Yahoo Finance
AMI Asset Management Corp Has $1.06 Million Stake in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International PLC (KNSA) Shares Surge 5. - GuruFocus
KNSA Maintained by Wedbush -- Price Target Raised to $72.00 - GuruFocus
Kiniksa Pharmaceuticals International, plc(NasdaqGS:KNSA) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Kiniksa Pharmaceuticals International, plc(NasdaqGS:KNSA) added to Russell 2500 Growth Benchmark - marketscreener.com
Kiniksa Pharmaceuticals International, plc(NasdaqGS: KNSA) added to Russell 2000 Index - marketscreener.com
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 12-Month High on Analyst Upgrade - MarketBeat
Kiniksa Pharmaceuticals International, plc(NasdaqGS:KNSA) added to Russell 2000 Growth Benchmark - marketscreener.com
Kiniksa Pharmaceuticals International, plc(NasdaqGS:KNSA) added to Russell 3000E Growth Benchmark - marketscreener.com
Kiniksa Pharmaceuticals International, plc(NasdaqGS: KNSA) added to Russell 3000E Index - marketscreener.com
Kiniksa Pharmaceuticals International (MEX:KNSAN) Cyclicall - GuruFocus
Kiniksa Pharmaceuticals International, plc(NasdaqGS:KNSA) added to Russell 2000 Growth-Defensive Index - marketscreener.com
Here's Why You Should Add Kiniksa Stock to Your Portfolio Now - Yahoo Finance
KNSA Forecast — Price Target — Prediction for 2027 - TradingView
Kiniksa Pharmaceuticals International, plc Class A Actuals & Estimates (BOATS:KNSA) - TradingView
Kiniksa Pharmaceuticals International PLC (KNSA) Stock Down 3.8% but Still Overvalued -- GF Score: 56/100 - GuruFocus
Kiniksa Pharmaceuticals International, plc Class A Actuals & Estimates (BMV:KNSA/N) - TradingView
Kiniksa Pharmaceuticals International, plc Class A Actuals & Estimates (BIVA:KNSA/N) - TradingView
KNSA/N Forecast — Price Target — Prediction for 2027 - TradingView
Kiniksa Pharmaceuticals International Plc (NASDAQ:KNSA) Presents a Compelling GARP Opportunity - ChartMill
US High Growth Tech Stocks to Watch - simplywall.st
Kiniksa Pharmaceuticals International, plc $KNSA Shares Bought by SG Americas Securities LLC - MarketBeat
Kiniksa Pharmaceuticals lifts revenue outlook, shares near record high - AD HOC NEWS
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 52-Week HighTime to Buy? - MarketBeat
Is Kiniksa Pharmaceuticals International PLC (KNSA) Overvalued A - GuruFocus
Here's why momentum in Kiniksa Pharmaceuticals International, plc (KNSA) should keep going - MSN
Kiniksa Pharmaceuticals International, plc (KNSA) upgraded to strong buy: Here's what you should know - MSN
Here's Why Momentum in Kiniksa Pharmaceuticals International, plc (KNSA) Should Keep going - Yahoo Finance
Kiniksa Pharmaceuticals International PLC - TradingKey
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Paolini John F. | CHIEF MEDICAL OFFICER |
May 01 '26 |
Sale |
53.71 |
58,424 |
3,137,823 |
65,623 |
0.17%
1.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):